Search company, investor...

Calpyso Medical

Founded Year



Other Investors | Alive

About Calpyso Medical

Calypso Medical provides technologies in the radiation oncology market

Headquarters Location

2101 Fourth Avenue 4th & Blanchard Building, Suite 500

Seattle, Washington, 98121,

United States

Missing: Calpyso Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Calpyso Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Calpyso Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Calpyso Medical is included in 1 Expert Collection, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Calpyso Medical Frequently Asked Questions (FAQ)

  • When was Calpyso Medical founded?

    Calpyso Medical was founded in 1999.

  • Where is Calpyso Medical's headquarters?

    Calpyso Medical's headquarters is located at 2101 Fourth Avenue, Seattle.

  • What is Calpyso Medical's latest funding round?

    Calpyso Medical's latest funding round is Other Investors.

  • Who are the investors of Calpyso Medical?

    Investors of Calpyso Medical include Frazier Healthcare Partners, RiverVest Venture Partners, Mosaix Ventures, Earlybird Venture Capital and Kaiser Permanente Ventures.

  • Who are Calpyso Medical's competitors?

    Competitors of Calpyso Medical include CivaTech Oncology, Augmenix, Pharmacyclics, Pathwork Diagnostics, Proterixbio and 11 more.

Compare Calpyso Medical to Competitors

Radiation Shield Technologies

Radiation Shield Technologies (RST) is the world leader in the research, design and production of personal protection systems for ionizing and nuclear radiation. The company's core technology, DemronTM , is specifically engineered to combine radiation protection with "ease of use" in order to maximize effective radiological defense. RST's primary goal is to ensure that all DemronTM products are of the highest protective quality. This is achieved by working closely with the company's end users, developing new standards of personal radiation protection, and meeting the specific needs of those groups most at risk of exposure. After almost a decade of development, RST is proud to introduce DemronTM to the industries, governments and everyday people who, until now, have had no options for true personal radiation protection.n

Xoft Microtube

Xoft is engaged in the practice of radiation oncology through electronic brachytherapy with its miniaturized x-ray tube technology. It's first product, the Axxent Electronic Brachytherapy System applies radiation directly to a tumor bed within the body without the use of radioactive isotopes, heavy shielding, or major capital equipment.

CivaTech Oncology Logo
CivaTech Oncology

Civatech Oncology is a medical device company focused on the development of polymer based devices that treat cancer using localized, low-dose-rate radiation. The company's fabrication methods allow for precise encapsulation of radioactive materials into polymer structures. These polymer-based brachytherapy devices offer physicians treatment options for tumors with low-dose-rate brachytherapy.

Smart Animal Logo
Smart Animal

Smart Animal is a medical devices company developing prototypes to enable patient-specific imaging and targeted therapy.

BioMicro Systems

BioMicro Systems was founded in 2000 to develop and improve microfluidic microarray sample processing. Microarrays are tools used by major pharmaceutical companies and research laboratories to sift through and analyze information contained within a genome. A microarray consists of different nucleic acid probes that are chemically attached to a substrate, which can be a microchip, a glass slide or microsphere-sized beads. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray instrument, designed to target the processing bottleneck encountered during the critical hybridization step in gene expression studies.

Supertron Technologies

Supertron Technologies is a developer of high performance clinical and preclinical imaging products for magnetic resonance imaging (MRI).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.